powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1053567743
Karl Nadolsky
DO
Endocrinology
Holland,
MI
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 230003
Hospital
CCN 230038
Hospital
CCN 230072
Hospital
CCN 230085
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
105
By payment type
Food and Beverage
$2K
Top paying entities
Food and Beverage
$2K
PRESCRIBING · PART D · 2024
Total Rx claims
2,936
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
39
Brand share
54.5%
Top prescribed drugs
Levothyroxine Sodium
381 claims
Tirzepatide
374 claims
Empagliflozin
227 claims
Pioglitazone Hcl
213 claims
Semaglutide
168 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
263
Unique beneficiaries
—
Total services
325
Distinct HCPCS
5
Medicare payment
$20K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 157 Endocrinology providers in MI — below median (cohort median 518).